Cargando…
The histone methyltransferase SETD2 negatively regulates cell size
Cell size varies between cell types but is tightly regulated by cell intrinsic and extrinsic mechanisms. Cell size control is important for cell function, and changes in cell size are frequently observed in cancer. Here, we uncover a role for SETD2 in regulating cell size. SETD2 is a lysine methyltr...
Autores principales: | Molenaar, Thom M., Malik, Muddassir, Silva, Joana, Liu, Ning Qing, Haarhuis, Judith H. I., Ambrosi, Christina, Kwesi-Maliepaard, Eliza Mari, van Welsem, Tibor, Baubec, Tuncay, Faller, William J., van Leeuwen, Fred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9659392/ https://www.ncbi.nlm.nih.gov/pubmed/36052643 http://dx.doi.org/10.1242/jcs.259856 |
Ejemplares similares
-
DOT1L inhibition does not modify the sensitivity of cutaneous T cell lymphoma to pan-HDAC inhibitors in vitro
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2022) -
Histone methyltransferase DOT1L controls state‐specific identity during B cell differentiation
por: Aslam, Muhammad Assad, et al.
Publicado: (2021) -
SETD2: from chromatin modifier to multipronged regulator of the genome and beyond
por: Molenaar, Thom M., et al.
Publicado: (2022) -
The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8(+) T cells
por: Kwesi-Maliepaard, Eliza Mari, et al.
Publicado: (2020) -
Conserved crosstalk between histone deacetylation and H3K79 methylation generates DOT1L‐dose dependency in HDAC1‐deficient thymic lymphoma
por: Vlaming, Hanneke, et al.
Publicado: (2019)